HBeAg negative patients with chronic hepatitis B are less likely to have a biochemical breakthrough during lamivudine treatment
Bildiriler > Özet Bildiri · 2005
Yazarlar: Ulus Salih AKARCA, F Gunsar, G Ersoz, T Ozacar, Memnune Selda ERENSOY, M Akyildiz, E Kasap, S Akay, Fatih TEKİN, Abdullah Zeki KARASU, Y Batur, T Ilter
40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Fransa, Uluslararası, Sözlü Sunum, Özet Bildiri, 2005-2005, Wos, cilt 42, ss 170-170